SCHEMBL7852521

SCHEMBL7852521

CCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.76
▸ CFTR P13569 1/20 0.71
▸ KMT2A Q03164 3/20 0.60
▸ MITF O75030 1/20 0.60
▸ MAPT P10636 2/20 0.60
▸ MEN1 O00255 2/20 0.60
▸ CTDSP1 Q9GZU7 2/20 0.60
▸ POLB P06746 1/20 0.60
▸ BLM P54132 1/20 0.60
▸ PTPN7 P35236 3/20 0.58
▸ PTPN12 Q05209 3/20 0.58
▸ GPR35 Q9HC97 3/20 0.58
▸ PTPN22 Q9Y2R2 3/20 0.58
▸ DDX3X O00571 2/20 0.58
▸ PSMD14 O00487 1/20 0.58
▸ MMP2 P08253 1/20 0.58
▸ GPR55 Q9Y2T6 1/20 0.58
▸ PDE4B Q07343 2/20 0.57
▸ ALDH1A1 P00352 1/20 0.55
▸ DNM1 Q05193 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18103053 0.86 MAPK1 (0.72) MAPK1CFTRKMT2AMITFMAPT
SCHEMBL4138637 0.86 MAPK1 (0.72) MAPK1CFTRKMT2AMITFMAPT
SCHEMBL20005672 0.86 MAPK1 (0.72) MAPK1CFTRKMT2AMITFMAPT
SCHEMBL4138638 0.86 MAPK1 (0.72) MAPK1CFTRKMT2AMITFMAPT
SCHEMBL19420026 0.86 MAPK1 (0.57) MAPK1CFTRKMT2AMITFMAPT
SCHEMBL1904246 0.85 MAPK1 (0.71) MAPK1KMT2AMAPTMEN1CTDSP1
SCHEMBL1904243 0.85 MAPK1 (0.71) MAPK1KMT2AMAPTMEN1CTDSP1
SCHEMBL1904245 0.85 MAPK1 (0.71) MAPK1KMT2AMAPTMEN1CTDSP1
SCHEMBL6886476 0.83 MAPK1 (0.75) MAPK1KMT2AMITFMAPTMEN1
SCHEMBL6886480 0.83 MAPK1 (0.75) MAPK1KMT2AMITFMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE THE BURNHAM INSTITUTE (US) 2010-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE APAF1, F11, SERPINB1 MAPK1 2525/4885CFTR 849/4885KMT2A 3345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback